Over-expression of P-glycoprotein in the canine brain following spontaneous status epilepticus

Epilepsy Research

Volumn 83, Issue 2-3, 2009, Pages 144-151

  Pekcec, A ^a   Unkruer B ^a   Stein, V ^b   Bankstahl, J P ^b   Soerensen, J ^a   Tipold, A ^b   Baumgartner W ^b   Potschka, H ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Blood brain barrier; Drug refractoriness; Efflux transporter; Multidrug transporter; P glycoprotein; Pharmacoresistance

Indexed keywords

GLYCOPROTEIN P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TISSUE; CLINICAL STUDY; CONTROLLED STUDY; DENTATE GYRUS; DOG; DRUG RESISTANCE; EFFUSION; EPILEPTIC STATE; GRANULE CELL; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TREATMENT OUTCOME;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DOGS; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; P-GLYCOPROTEIN; PARIETAL LOBE; STATISTICS, NONPARAMETRIC; STATUS EPILEPTICUS; UP-REGULATION;

EID: 58849093964     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.10.010     Document Type: Article

References (27)

1. Aronica E., Gorter J.A., Jansen G.H., van Veelen C.W., van Rijen P.C., Leenstra S., Ramkema M., Scheffer G.L., Scheper R.J., and Troost D. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience 118 (2003) 417-429
2. Aronica E., Gorter J.A., Ramkema M., Redeker S., Ozbas-Gerceker F., van Vliet E.A., Scheffer G.L., Scheper R.J., van der Valk P., Baayen J.C., and Troost D. Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia 45 (2004) 441-451
3. Bauer B., Hartz A.M., Pekcec A., Toellner K., Miller D.S., and Potschka H. Seizure-induced upregulation of P-glycoprotein at the blood-brain barrier through glutamate and COX-2 signaling. Mol. Pharmacol. 73 (2008) 1444-1453
4. Brandt C., Bethmann K., Gastens A.M., and Loscher W. The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiol. Dis. 24 (2006) 202-211
5. Cucullo L., Hossain M., Rapp E., Manders T., Marchi N., and Janigro D. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs. Epilepsia 48 (2007) 505-516
6. Czasch S., Paul S., and Baumgartner W. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain. Neurobiol. Aging 27 (2006) 293-305
7. Dombrowski S.M., Desai S.Y., Marroni M., Cucullo L., Goodrich K., Bingaman W., Mayberg M.R., Bengez L., and Janigro D. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 42 (2001) 1501-1506
8. Hoffmann K., Gastens A.M., Volk H.A., and Loscher W. Expression of the multidrug transporter MRP2 in the blood-brain barrier after pilocarpine-induced seizures in rats. Epilepsy Res. 69 (2006) 1-14
9. Kuwahara S., Sada Y., Moriki T., Yamane T., and Hara H. Spatial and temporal expression of P-glycoprotein in the congenitally hydrocephalic HTX rat brain. Pathol. Res. Pract. 192 (1996) 496-507
10. Kwan P., and Brodie M.J. Refractory epilepsy: mechanisms and solutions. Expert. Rev. Neurother. 6 (2006) 397-406
11. Loscher W. Animal models of intractable epilepsy. Prog. Neurobiol. 53 (1997) 239-258
12. Loscher W., and Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat. Rev. Neurosci. 6 (2005) 591-602
13. Loscher W., Potschka H., Rieck S., Tipold A., and Rundfeldt C. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures. Epilepsia 45 (2004) 1228-1239
14. Marchi N., Guiso G., Rizzi M., Pirker S., Novak K., Czech T., Baumgartner C., Janigro D., Caccia S., and Vezzani A. A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine. Epilepsia 46 (2005) 1613-1619
15. Pekcec A., Baumgartner W., Bankstahl J.P., Stein V.M., and Potschka H. Effect of aging on neurogenesis in the canine brain. Aging Cell 7 (2008) 368-374
16. Porrello A., Cardelli P., and Spugnini E.P. Oncology of companion animals as a model for humans. An overview of tumor histotypes. J. Exp. Clin. Cancer Res. 25 (2006) 97-105
17. Rigau V., Morin M., Rousset M.C., de Bock F., Lebrun A., Coubes P., Picot M.C., Baldy-Moulinier M., Bockaert J., Crespel A., and Lerner-Natoli M. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain 130 (2007) 1942-1956
18. Rizzi M., Caccia S., Guiso G., Richichi C., Gorter J.A., Aronica E., Aliprandi M., Bagnati R., Fanelli R., D'Incalci M., Samanin R., and Vezzani A. Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance. J. Neurosci. 22 (2002) 5833-5839
19. Sills G.J., Kwan P., Butler E., de Lange E.C., van den Berg D.J., and Brodie M.J. P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice. Epilepsy Behav. 3 (2002) 427-432
20. Sisodiya S.M., Lin W.R., Harding B.N., Squier M.V., and Thom M. Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125 (2002) 22-31
21. Sisodiya S.M., and Thom M. Widespread upregulation of drug-resistance proteins in fatal human status epilepticus. Epilepsia 44 (2003) 261-264
22. Toth K., Vaughan M.M., Peress N.S., Slocum H.K., and Rustum Y.M. MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. Am. J. Pathol. 149 (1996) 853-858
23. van Vliet E., Aronica E., Redeker S., Marchi N., Rizzi M., Vezzani A., and Gorter J. Selective and persistent upregulation of mdr1b mRNA and P-glycoprotein in the parahippocampal cortex of chronic epileptic rats. Epilepsy Res. 60 (2004) 203-213
24. van Vliet E.A., van Schaik R., Edelbroek P.M., Redeker S., Aronica E., Wadman W.J., Marchi N., Vezzani A., and Gorter J.A. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia 47 (2006) 672-680
25. van Vliet E.A., van Schaik R., Edelbroek P.M., Voskuyl R.A., Redeker S., Aronica E., Wadman W.J., and Gorter J.A. Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats. J Pharmacol. Exp. Ther. 322 (2007) 141-147
26. Volk H.A., Potschka H., and Loscher W. Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats. Epilepsy Res. 58 (2004) 67-79
27. Volk H., Potschka H., and Loscher W. Immunohistochemical localization of P-glycoprotein in rat brain and detection of Ist increased expression by seizures are sensitive to fixation and staining variables. J. Histochem. Cytochem. 53 (2005) 517-531